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ABSTRACT
MicroRNAs (miRNAs) typically downregulate protein
expression from target mRNAs through limited
base-pairing interactions between the 50 ‘seed’
region of the miRNA and the mRNA 30 untranslated
region (30UTR). In contrast to this established mode
of action, the liver-specific human miR-122 binds
at two sites within the hepatitis C viral (HCV)
50UTR, leading to increased production of infectious
virions. We show here that two copies of miR-122
interact with the HCV 50UTR at partially overlapping
positions near the 50 end of the viral transcript to
form a stable ternary complex. Both miR-122
binding sites involve extensive base pairing
outside of the seed sequence; yet, they have sub-
stantially different interaction affinities. Structural
probing reveals changes in the architecture of the
HCV 50UTR that occur on interaction with miR-122.
In contrast to previous reports, however, results
using both the recombinant cytoplasmic exonucle-
ase Xrn1 and liver cell extracts show that
miR-122-mediated protection of the HCV RNA from
degradation does not correlate with stimulation of
viral propagation in vivo. Thus, the miR-122:HCV
ternary complex likely functions at other steps
critical to the viral life cycle.
INTRODUCTION
The liver-specific miRNA miR-122 is required for replica-
tion and translation of hepatitis C virus (HCV), a
hepatotropic positive-sense RNA virus that can cause cir-
rhosis and hepatocellular carcinoma (1–3). Accounting for
>50% of mature miRNAs in hepatocytes (4), miR-122
binds to the 50UTR of HCV mRNA in infected cells and
augments viral transcript stability and production of in-
fectious virions (5). Although inhibition of miR-122 by
anti-sense oligonucleotides is an effective anti-viral thera-
peutic strategy (6,7), the mechanism by which miR-122
enhances viral propagation remains incompletely
understood.
Several lines of evidence suggest that miR-122 stimu-
lates HCV infection by a mechanism that is distinct
from miRNA-mediated attenuation of gene expression.
Studies using mutated versions of miR-122 and HCV in
cell culture revealed two binding sites for miR-122 near
the 50 end of the viral mRNA, in contrast to the typical
location of miRNA binding sites within transcript 30UTRs
(8). Furthermore, both miR-122:HCV binding sites
involve base pairing along the length of the miR-122
sequence, contrary to the predominant role of base
pairing between nucleotides 2–8 at the 50 end of
miRNAs (the ‘seed region’) and their target mRNA
binding sites (9,10) (Figure 1A). Finally, the miR-
122:HCV interaction does not induce translational repres-
sion and/or deadenylation of the mRNA and does not
trigger mRNA degradation, counter to the canonical
effects induced by miRNAs (11,12). Importantly,
miR-122 can function by this canonical pathway to
downregulate host liver cell transcripts, primarily target-
ing genes involved in lipid and cholesterol metabolism
(13–15). These observations suggest that HCV co-opts
the host miR-122 to promote viral production by means
of a distinct pathway (16,17).
Using a combination of biochemical and biophysical
techniques, we show here that two copies of miR-122
bind simultaneously to the HCV 50UTR but with
unequal affinities. The resulting heterotrimeric interaction
induces a stable structure that is distinct from the structure
of the HCV 50UTR alone. Although the miR-122:HCV
structure resists degradation by the major cytoplasmic
exonuclease Xrn1, this effect occurs even with mutant
versions of miR-122 that do not enhance viral propaga-
tion in cell culture (9,10). This finding suggests that
beyond direct stabilization of viral transcripts, the
miR-122:HCV structure may recruit other viral or host
factors or act to regulate other structures within the
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HCV 50UTR and/or genome. These results reveal a mech-
anism of miRNA action in post-trancriptional gene regu-
lation that involves structural changes induced on
formation of the miRNA:HCV complex.
MATERIALS AND METHODS
Synthesis of HCV 50UTR RNA
For selective 20-hydroxyl acylation analysed by primer
extension (SHAPE) analysis, a DNA template for tran-
scription inserted in the context of 50 and 30 flanking
sequences (18) was prepared using PCR [1 mL; 20mM
Tris (pH 8.4), 50mM KCl, 2.5mM MgCl2, 200 mM each
NTP, 0.5 mM each forward and reverse primer, 1 mg DNA
template and 0.025U/mL of Taq polymerase; denaturation
at 94C, 45 s; annealing 60C, 30 s; and elongation 72C,
1min; 34 cycles] from the plasmid pKB101, a variation of
pKB84 that includes domain I (19), using the following
primers: forward 50-TAATACGACTCACTATAGGCCT
TCGGGCCAAGCCAGCCCCCTGATGGGGG-30 and
reverse 50-GAACCGGACCGAAGCCCGATTTGGTTT
TTCTTTGAGGTTCAGGATTTGTGCTC-30. For iso-
thermal titration calorimetry (ITC) experiments, a DNA
template for transcription was prepared by linearization of
pKB101 with BamHI (NEB). Transcription reactions
(100mL for SHAPE, 5.0mL for ITC, 37C for 3–4 h) con-
tained 30mM Tris (pH 8.0), 25mMMgCl2, 2mM spermi-
dine, 0.01% (v/v) Triton X-100, 5mM each NTP, 1 mg/mL
of inorganic pyrophosphatase (Roche), 50 mg/mL of DNA
template, 0.1mg/mL of T7 RNA polymerase and
0.12U/mL of RNase Inhibitor (Promega). The RNA for
ITC was purified by denaturing polyacrylamide gel elec-
trophoresis (8% 29:1 acrylamide:bisacrylamide, 7M
Urea), whereas the RNA for SHAPE experiments was
purified using the RNA clean and concentrator-25 kit
(Zymo research).
Electrophoretic mobility shift assays with HCV
dom I RNA
RNA oligonucleotides corresponding to HCV dom I and
native and mutant miR-122 RNAs were synthesized by
Integrated DNA Technologies (IDT). HCV dom I RNA
(8mM) was heated at 65C for 5min and cooled to 35C
before addition of native or mutant miR-122 RNAs in
molar ratios of 0, 0.5, 1.0, 1.5, 2.0 and 3.0 and incubated
at 37C for 20–30min in a 5 mL volume containing
100mM HEPES (pH 7.5), 100mM KCl and 5mM
MgCl2. An equal volume of gel-loading dye (30%
glycerol, 0.5 TBE and 6mM MgCl2) was added before
separation using non-denaturing gel electrophoresis
Figure 1. HCV domain I binds two copies of miR-122. (A) Model of
the interaction of HCV dom I (black) with miR-122 (grey). (B)
Non-denaturing gel electrophoresis mobility shift assay performed in
the presence of 5mM Mg2+ and increasing amounts of miR-122. (C)
Thermogram and resulting binding curve for the titration of HCV dom
I with miR-122. The dissociation constants are the mean of three rep-
licates with error propagated from the three individual binding curve
Figure 1. Continued
fits. (D and E) SHAPE reactivities of HCV dom I in the absence (D)
and presence (E) of 10 mM miR-122. Reactivities are represented as the
mean of three replicates with standard deviation shown as error bars.
Reactivities are superimposed on the secondary structures according the
legend in (D) with the exception of nucleotides 17–31 of dom I, which
are omitted in data analysis owing to high background from a large
reverse transcriptase stop in the raw electropherogram (Supplementary
Figure S2A). (F) SHAPE reactivities superimposed on the secondary
structure model of the entire HCV 50UTR RNA colored as in (D).
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(12% 29:1 acrylamide:bisacrylamide, 0.5 TBE, 6mM
MgCl2) 8W, 4
C, 2.5 h). RNA was visualized by
staining with SYBR Gold (Invitrogen).
Isothermal titration calorimetry
RNA samples were folded by diluting (100 mL of
100mM—1mM stock) into 15mL of buffer containing
100mM HEPES (pH 7.5), 100mM KCl and 0 or 5mM
MgCl2 and heating to 65
C for 10min and cooling on ice
for 10min. RNA samples were subsequently concentrated,
washed twice with buffer and concentrated to an appro-
priate volume for ITC experiments. HCV RNA was
present in the cell at a concentration of 5 mM for all titra-
tions with miR-122 RNA except for the p8p9 mutant
where a concentration of 10–20 mM was used to account
for the lower affinity of the interaction. MiR-122 RNAs
were present in the syringe at slightly greater than 10-fold
molar excess except for the titration of HCV dom I RNA
with native and p8p9 miR-122 RNAs and the titration of
HCV 50UTR and s2 RNA with native miR-122, in which
case the miRNAS were used at a slightly greater than
20-fold molar excess to account for the possibility of 2:1
binding. ITC experiments were performed on an ITC200
(MicroCal) instrument at 37C, with a reference power of
3 mcal/s. In a typical experiment, we performed twenty
2.0mL injections of miR-122 into the cell containing
HCV RNA, with a duration of 4.0 s per injection and
180-s spacing. Experiments were performed in triplicate
for all HCV constructs. The first injection was discarded,
and the data were fitted to either a single- or two-site
binding model using Origin 7 (MicroCal).
SHAPE analysis
HCV 50UTR RNA in the context of 50 and 30 flanking
sequences (see earlier in the text) was modified with 1M7
(3.5mM, final) as described previously (20). MiR-122
RNAs were present at a final concentration of 10 mM,
with the exception of the p8p9 miR-122, which was at a
concentration of 20 mM, and incubated with folded HCV
50UTR for 20–30min at 37C before modification. The
general procedure of primer extension and data analysis
was according to that outlined elsewhere (21).
Electrophoretic mobility shift assays with HCV s1
and s2 RNAs
MiR-122 RNAs (IDT) were 5032P-labelled using
[g-32P]ATP (PerkinElmer) and T4 PNK (NEB) [10 mL of
reaction; 1 T4 PNK buffer, 50 pmol miR-122 RNA,
50 mCi [g-32P]ATP, 10 U T4 PNK] at 37C for 1 h and
subsequently diluted with nuclease-free water (40mL).
Excess [g-32P]ATP was removed using a G25 spin
column (GE healthcare), and the resulting radio-labelled
miR-122 RNAs were used without further purification.
HCV s1 and s2 RNAs were folded by heating at 65C
for 5min and cooling on ice for 5–10min in folding
buffer [5 mM MgCl2, 100mM KCl and 100mM HEPES
(pH 7.5)]. The pre-folded s1 and s2 RNAs were serial
diluted by 2-fold in folding buffer to obtain desired con-
centration range before incubation with 3000 cpm/mL
(0.5–1 pmol) in a 5 mL of reaction for 20–30min at
37C. An equal volume of gel-loading dye (30%
glycerol, 0.5 TBE and 6mM MgCl2) was added before
separation using non-denaturing gel electrophoresis (14%
29:1 acrylamide:bisacrylamide, 0.5 TBE, 6mM MgCl2)
8W, 4C, 2.5 h). RNA was visualized by phosphorimaging
using a Storm840 (GE healthcare).
Xrn1 nuclease activity assays
50phosphorylated and 30 32P-labelled RNA substrates were
prepared by labelling a synthetic RNA oligonucleotide
corresponding to nucleotides 1–47 of HCV genotype 1b
(IDT) with [50-32P]pCp and T4 RNA ligase (NEB) [30 mL
of reaction; 1 T4 RNA ligase buffer (NEB), 1mM ATP,
10% (v/v) DMSO; 100 pmol RNA, 1 mM [50-32P]pCp
(PerkinElmer) and 10 U T4 RNA ligase] overnight at
16C and subsequently 50phosphorylated using T4 PNK
(10 U) for 1 h at 37C. Excess ATP and 50-32P]pCp were
removed using a G25 spin column (GE Healthcare); the
resulting radiolabelled RNAs were used without further
purification. Assays were carried out in 1 Xrn1 buffer
[20 mMHEPES (pH 7.5), 100mMKCl, 4mMMgCl2, 5%
(v/v) glycerol, 1mM DTT] with 1 mg of hXrn1 and
2 pmol RNA substrate at 25C for 1min to 3 h.
Reactions were quenched by addition of an equal
volume of RNA-loading dye [95% (v/v) deionized
formamide, 5mM ethylenediaminetetraacetic acid (pH
8.0), 0.025% (w/v) sodium dodecyl sulphate]. Native and
mutant miRNAs (10 mM, final) were incubated for 30min
at 25C with labelled RNA substrate before addition of
Xrn1. The reaction products were resolved by running the
samples on a 16% polyacrylamide/7M urea gel.
RNA stability in HepG2 lysate
HepG2 lysate was prepared according to standard proto-
cols (22). 50phosphorylated and 30 32P-labelled RNA sub-
strates prepared as in Xrn1 assays were incubated in
HepG2 lysate at 25C for 0.01–3 h in the presence of
5mM MgCl2, 100mM KCl and 100mM HEPES (pH
7.5). The assay was performed identically to the Xrn1
activity assay except in the case of 50phosphorylated
miR-122, which was incubated with extract before
addition of RNA substrate to allow for loading into Ago2.
RESULTS AND DISCUSSION
MiR-122 binds at two non-equivalent sites in the
HCV 50 UTR
Two distinct binding sites for miR-122 were previously
identified within the HCV 50UTR based on sequence con-
servation and compensatory base-pairing mutations (8,9).
However, whether HCV forms a stable complex with two
copies of miR-122 simultaneously was not known. To test
this possibility, we incubated an RNA derived from the
HCV genotype 1b consisting of both predicted miR-122
binding sites with increasing concentrations of miR-122.
The resulting miR-122:HCV complexes were resolved by
non-denaturing gel electrophoresis (Figure 1B). The HCV
transcript showed a retarded mobility on addition of one
molar equivalent of miR-122, and this complex was
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further retarded on addition of two molar equivalents of
miR-122, indicating formation of a stable trimeric
complex. No further mobility shift occurred with add-
itional miR-122, and excess miR-122 was observed as a
faster migrating band in the gel under these conditions.
These data show that a stable tri-molecular complex forms
between the HCV 50UTR and two copies of miR-122.
We next tested the affinities of the two miR-122 RNAs
for their binding sites in the HCV RNA. Although the
location and extent of base pairing is predicted to be
similar for sites 1 and 2 (Figure 1A), based on current
models, there is potential for overlap in base pairing
between the two sites, which could lead to unequal
affinities and competition for binding. Binding affinities
for the interaction between HCV domain I (dom I, nu-
cleotides 1–47) and miR-122 RNA were measured using
ITC. Using established conditions, miR-122 was titrated
into a solution of pre-annealed HCV dom I RNA, result-
ing in a strongly exothermic interaction (H=141 kcal/
mol) indicating an enthalpically favourable interaction
(Figure 1C, top panel and Supplementary Table S1).
The binding curve was best fit with a two-site binding
model, yielding equilibrium dissociation constants (Kds)
of 90 (n=0.94) and 845 nM (n=0.94) (Figure 1C,
bottom panel and Table 1). This result indicates that
miR-122 has different affinities for site 1 compared with
site 2 in the HCV 50 UTR. In liver cells, where the con-
centration of miR-122 is likely to be in the low nM range
(66 000 copies/cell) (4), these two partially overlapping
miR-122 binding sites may compete for occupancy. ITC
was also performed on the interaction between miR-122
and dom I in the context of the full-length HCV 50UTR
[dom I+internal ribosome entry site (IRES), nucleotides
1–371], with a result in overall agreement with that for the
HCV dom I RNA alone (Supplementary Figure S1A,
Table 1 and Supplementary Table S1).
To investigate the molecular origin of the distinct
affinities for the two binding sites in dom I, we performed
SHAPE (20) on the full-length HCV 50UTR (nucleotides
1–371) in the presence and absence of miR-122 RNA
(Figures 1D–F and 2 and Supplementary Figures S2 and
S3). SHAPE provides nucleotide resolution information
on local nucleotide flexibility and provides structural in-
formation for each nucleotide in the RNA sequence (23).
When SHAPE was performed on the HCV 50UTR alone,
reactivity information was obtained for almost every
nucleotide in the RNA (Supplementary Figure S2A) and
agrees well with the current structural model (24,25)
(Figure 1F). The reactivities observed for dom I reveal
that site 2 is unstructured, and although most of the struc-
tural details for site 1 are obscured (Supplementary Figure
S2A), the extreme 50 end is also relatively unstructured
(Figure 1D). When SHAPE was performed on the HCV
50UTR in the presence of miR-122, reactivities indicated
that the RNA folds into a similar structure outside of dom
I (Figure 2 and Supplementary Figure S3). Within dom I,
however, a large decrease in reactivity was observed in site
2 (Figures 1E and 2). When the dom I reactivities are
superimposed on the RNA secondary structure, it is
apparent that the extent of base pairing at site 2 is
greater than originally proposed (Figure 1A). These
results support a base-pairing pattern similar to a recent
model (25), which would increase the stability of the inter-
action of miR-122 at site 2 compared with site 1
(Figure 1E). We also observed a reproducible decrease
in reactivity at the extreme 50 end of the HCV RNA, con-
sistent with miR-122 binding at site 1. Other reproducible
differences in reactivity occur outside of dom I on
miR-122 binding, mostly within the pseudoknot and
dom IV regions, this agrees with what has been observed
in other similar experiments and is an intriguing result
(25). There is also a prominent increase in reactivity
within the bulged region in dom IIa (Figure 2). Notably,
dom IIa and IIb has also been observed to have increased
SHAPE reactivity and hence flexibility in the absence of
dom I [see Supplementary Figure S6b in (24)].
Interestingly, the dom IIa bulge is the binding site of an
inhibitor of viral translation and affects the dynamics and
tertiary structure in dom II (26). These SHAPE-reactivity
changes could result from changes in the global tertiary
structure that arise on binding of miR-122 to dom I,
including possible stacking interactions between the two
duplexes that form as a result of binding and/or disruption
of an interaction between dom I and IIa. These results are
intriguing, but further work needs to be done to address
these possibilities entirely and in greater detail. Dom I is
located immediately adjacent to the HCV IRES, which
comprises the rest of the 50UTR and is necessary for
viral translation. Although evidence for modest
miR-122-mediated stimulation of HCV translation is con-
troversial (27,28), binding of miR-122 to dom I could
affect the interaction of this domain with the HCV
Table 1. ITC analysis of miR-122 binding by HCV 50UTR RNA constructs
HCV RNA (nt) Site 1 (1–30) Site 2 (21–47) Dom I (1–47) 50 UTR (1–371)
miR-122 RNA Mg2+ (mM) Kd (nM)
a Kd Kds1 Kds2 Kds1 Kds2
Native 5 14±6.2 13±9.6 845±354 90±52 11 600±9400 208±80
p3p4 5 n.b. 35±8.8 n.b. 120±25 n.b. 32±9.2b
p8p9 5 + 235±133b + 2306±1041 + +
Native 0 n.b. 72±14 n.b. 130±33 n.b. 19±6.3b
aValues reported are means of three measurements±error propagated from individual fits.
bValues reported are means of two measurements.
n.b.=no binding observed; +=binding observed but Kd not determined.
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IRES and hence influence viral translation by altering the
global structure of this region. Although we do not
observe enhanced binding affinity of the HCV IRES to
the 40S ribosomal subunit in the presence of miR-122
(S.A.M and J.A.D. unpublished results), miR-122
binding could have a kinetic effect on translation initiation
or trigger a more complex chain of events in other aspects
of the viral RNA life cycle.
HCV domain I interacts with miR-122 using extensive
base pairing outside the seed region
Most miRNA:target interactions are sensitive to muta-
tions in the base pairs within the canonical seed
sequence consisting of nucleotides 2–8 of the miRNA
(12). In agreement with this finding, mutation of base
pairs 3 and 4 (p3p4, Figure 1A) is detrimental to
miR-122 function in HCV RNA upregulation when
directed at both site 1 and site 2 (2,8). We wanted to test
the contribution of these seed-sequence base pairs, as well
as that from base pairs that form downstream of the ca-
nonical seed sequence (p8p9, Figure 1A), to the stability of
the miR-122:HCV complex. We first assessed the ability of
the mutated miR-122 RNAs, p3p4 and p8p9, to form a
stable complex with HCV dom I RNA using an electro-
phoretic mobility shift assay. When HCV dom I was
incubated with increasing molar equivalents of p3p4
miR-122 and resolved on a non-denaturing polyacryl-
amide gel, a single slower-migrating species was detected
(Figure 3A, left hand lanes). When HCV dom I was
incubated with the p8p9 miR-122, two slower-migrating
species were observed as with the native miR-122
sequence, although the poor resolution of the complex
suggests that it is less stable compared with the native
complex (compare right hand lanes in Figure 3A with
Figure 1B). These data indicate that both the seed
region and downstream base pairing are important to
the stability of this miRNA:target interaction.
To more quantitatively assess the contribution of each
base-pairing region to the stability of the complex, ITC
was performed using the p3p4 and p8p9 miR-122 mutated
sequences. When p3p4 miR-122 was titrated into folded
HCV dom I, the resulting thermogram revealed a strongly
exothermic binding interaction (H=118 kcal/mol,
Supplementary Table S1) with a resulting 1:1 binding
curve (n=0.94) and a Kd of 120 nM (Figure 3B, left
panel). Although only one copy of the mutated miR-122
binds, it binds with similar affinity to the native miR-122
sequence (Table 1, <2-fold difference). The thermogram
produced from the titration of p8p9 miR-122 mutation
into HCV dom I was less exothermic (H=26.5 kcal/
mol, Supplementary Table S1) and again resulted in an
approximate 1:1 binding curve (n=0.67) but with a much
weaker Kd of 2.3 mM (Figure 3B, right panel). Binding of a
second miR-122 is not observed, even though a ratio of
almost 5:1 miR-122:HCV dom I was reached during the
course of the titration, suggesting the Kd is weaker than
can be measured by ITC (see ‘Materials and Methods’
section). The affinity of the p8p9 miR-122 for HCV dom
I is significantly lower than that of both the p3p4 and
native miR-122 sequences (19 and 26-fold, respect-
ively), indicating that those base pairs contribute greatly
to the overall stability of the miRNA:target interaction.
This result is in contrast to what has been observed for
canonical miRNA:target interactions, where downstream
base pairing is not as vital to miRNA function and
binding stability (12). Furthermore, these results show
that the two miR-122 binding sites behave differently.
Figure 2. Observed changes in reactivity upon miR-122 binding to the full length HCV 50UTR. (A) Step plot comparing quantified and normalized
SHAPE reactivities obtained in the absence (black line) or presence (grey line) of native miR-122. (B) Difference plot showing changes in reactivity
on binding of miR-122. Significant increases in reactivity (more than 0.3 SHAPE units) are highlighted in red, whereas substantial decreases in
reactivities (more than 0.3 SHAPE units) are shown in blue. (C) Changes in reactivity on binding of miR-122 superimposed on the proposed
secondary structure of the HCV 50UTR coloured as in (B).
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At one site, the contribution of binding energy from the
seed sequence is imperative to the overall stability of the
interaction, whereas at the other site, the seed sequence
pairing contributes only marginally to the overall inter-
action stability. These results further support the conclu-
sion that miR-122 has much higher affinity for one site
versus the other.
HCV domain 1 site 2 is the high affinity site for miR-122
owing to extensive base pairing outside the seed sequence
As the two sites display different behaviour with respect to
their interaction with miR-122, despite somewhat similar
sequences, we designed RNAs that represent site 1 and site
2 (named s1 and s2, respectively) independently to deter-
mine which is the high-affinity site (Figure 4A). To
examine how these two sets of RNAs bind the native
miR-122 sequence, we performed both electrophoretic
mobility shift assays with 32P-labelled miR-122
(Figure 4B) and ITC experiments (Supplementary Figure
S4). Both s1 and s2 RNAs are capable of binding miR-122
with nearly identical Kd values of 14 and 13 nM, respect-
ively (Table 1). These findings contrast with the affinities
measured when the two sites are juxtaposed in the context
of dom I, indicating the two sites compete for binding with
miR-122 and are therefore partially overlapping.
Strikingly, when the same mobility shift assay is
performed using p3p4 miR-122, no binding is observed
with up tomM amounts of s1 RNA, whereas binding to
s2 is observed in the low nM range (Figure 4C). These
results support the notion that miR-122 has very different
affinities for the two binding sites within the HCV 50UTR.
Interestingly, site 1 resembles a canonical miRNA:target
site based on the necessity of a seed sequence in the inter-
action, whereas the same mutations in the site 2 seed
sequence contribute little to the overall binding energy
and stability of the interaction. HCV s1 and s2 RNAs
are both capable of binding 32P-labelled p8p9 miR-122,
albeit much more weakly compared with native miR-122
(Supplementary Figure S4). The fact that s1 RNA can still
bind the p8p9 mutated miR-122, but not the p3p4 mutated
miR-122, is reminiscent of a more conventional
miRNA:target interaction, with the seed sequence
contributing more to the interaction compared with any
downstream base pairing that occurs. Conversely, in site 2,
downstream base pairing is much more important for the
stability of the miRNA:HCV interaction compared with
the seed sequence. This is an unanticipated result in light
of our current understanding of miRNA:target
interactions.
We then performed SHAPE on the HCV 50UTR in the
presence of both the p3p4 and p8p9 miR-122 RNAs to
investigate the structural impact of binding by these
Figure 3. The interaction between HCV dom I and miR-122 is sensitive to mutations within and downstream of the seed sequence. (A)
Electrophoretic mobility shift assay with mutated miR-122 sequences. The p3p4 miR-122 contains seed sequence mutations (left panel) and the
p8p9 miR-122 contains downstream base pairing mutations (right panel). No slower migrating species were observed at concentrations of the p3p4
mutant higher than two molar equivalents relative to the HCV RNA. (B) Thermograms and resulting binding curves for the titration of HCV dom I
with p3p4 (left) and p8p9 (right) miR-122 RNA mutants. (C and D) SHAPE reactivities of HCV dom I in the presence of 10 mM p3p4 miR-122 (C,
purple outline) or 20 mM p8p9 miR-122 (D, cyan outline) compared with native miR-122 (grey outline). Reactivities shown are the mean of three
replicates and are superimposed on the secondary structures according the legend in Figure 1D.
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mutated sequences. Overall, the reactivity pattern for the
50UTR in the presence of each mutated miR-122 RNAs is
similar to that observed for the native sequence
(Supplementary Figure S5A and B). Careful inspection
of the dom I reactivities in the presence of p3p4
miR-122 reveals a large increase in reactivity at nucleo-
tides 40–42 and a small but reproducible increase in re-
activity at nucleotides 1–4 (Figure 3C). The rest of the
base pairing at site 2 is seemingly undisturbed by this
local mutation and is consistent with the overall similar
binding behaviour compared with that of native miR-122
RNA. The reactivity increase at nucleotides 1–4 is consist-
ent with a lack of binding of the p3p4 miR-122 at this site
(Figure 3C). Overall, the reactivities of dom I increase in
the presence of p8p9 miR-122 compared with native
miR-122 (Figure 1D). The seed sequence complement of
site 2 remains mostly unreactive, whereas the downstream
sequence becomes moderately reactive. This suggests a
much less stable interaction in which the base pairs
outside the seed sequence are incompletely or transiently
formed, which explains the lower affinity observed for site
2 via gel shift and ITC experiments. Similarly, the
reactivities at nucleotides 1–4 are increased in the
presence of p8p9, indicating loss of the downstream base
pairing at site 1.
These results suggest that both the seed sequence and
downstream pairing are important contributors to the
overall stability and hence to the function of the inter-
action of miR-122 with HCV RNA. Surprisingly, the con-
tribution of seed sequence and downstream base pairing is
not equivalent in the two sites. Site 1 behaves similarly to a
canonical miRNA:target interaction, whereas site 2 forms
an unconventional and high-affinity interaction with a
miRNA, driven by extensive base pairing outside of the
canonical seed sequence interaction. As a stable
tri-molecular complex forms between two potentially
overlapping copies of miR-122 and HCV transcripts
with extensive base pairing, the question of whether any
higher-order interactions contribute to the stability of the
complex still remains.
The miR-122:HCV complex comprises higher-order
interactions
As a step towards understanding whether tertiary inter-
actions play an important role in forming this unconven-
tional miRNA:target interaction, we tested the ability of
miR-122 to bind HCV dom I RNA in the absence of mag-
nesium ions. Withholding Mg2+prevents the formation of
RNA tertiary structures and therefore may alter the ac-
cessibility of the RNA structures. We incubated HCV
dom I RNA with increasing molar amounts of miR-122
RNA in the absence of Mg2+. When we resolved the re-
sulting complexes using non-denaturing poly-acrylamide
Figure 4. Determination of site 1 and site 2 interactions with miR-122 RNAs. (A) Proposed base-pairing interactions of each site individually with
miR-122. The sequence of the site 1 (s1) and site 2 (s2) RNAs are meant to represent binding to miR-122 independently. The s2 RNA is capable of
weak binding to a second copy of miR-122 owing to the presence of the s1 seed sequence (nucleotides 22–29) within the s2 RNA. Electrophoretic
mobility shift assays of s1 and s2 RNAs with 32P-labelled native (B) and p3p4 (C) miR-122 and (D) in the absence of Mg2+ ions.
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gel electrophoresis, we observed one copy of miR-122
bound stably to HCV dom I but did not observe a
slower migrating complex beyond a 1:1 ratio of miR-
122:HCV (Figure 5A). This result indicates that formation
of the native complex is severely hindered and that a
higher-order structure may be formed that requires stabil-
ization by Mg2+. We quantified the affinity for miR-122 to
HCV dom I in the absence of Mg2+ using ITC. When
HCV dom I is titrated with miR-122 in the absence of
Mg2+, the resulting thermogram is strongly exothermic
(H=130 kcal/mol, Supplementary Table S1) with a
binding curve best fit to a 1:1 binding model (n=0.999)
with a Kd of 130 nM (Figure 4B). The affinity of miR-122
for HCV in the absence of Mg2+ is only 1.4-fold weaker
compared with the affinity of native miR-122 for site 2
when Mg2+ is present (Table 1). When we performed the
same experiment in the context of the entire HCV 50UTR,
we obtained a similar result (Table 1 and Supplementary
Figure S1C). To conclusively determine which miR-122
binding site is impaired in the absence of Mg2+, we
performed electrophoretic mobility shift assays with
32P-labelled native miR-122 RNA and the s1 and s2
RNAs. No significant binding was observed with s1
RNA up to concentrations of 3 mM. Conversely, when
s2 was added, binding was observed in the lownM range
(Figure 4D). This result supports the notion that site 2 is
the more stable site, and that formation of the fully func-
tional trimeric complex between miR-122 and HCV RNA
requires Mg2+ to stabilize higher-order interactions within
the complex.
We also investigated Mg2+-induced structural changes
in the HCV 50UTR in the absence and presence of
miR-122. To do this, we performed SHAPE with and
without miR-122 in the absence of Mg2+. Overall, the re-
activity pattern of the HCV 50UTR in the presence and
absence of miR-122 when Mg2+ is absent is similar
(Supplementary Figure S5C). Inspection of the reactivities
for dom I reveals that site 2 is bound by miR-122, as
evident from the substantial decrease in reactivities of nu-
cleotides 32–43. The reactivities for nucleotides 1–4
Figure 5. The interaction between HCV dom I and miR-122 requires Mg2+ ions. (A) Electrophoretic mobility shift assay with HCV dom I and
increasing amounts of miR-122 performed in the absence of magnesium. (B) Thermogram and resulting binding curve of the titration of HCV dom I
with native miR-122 in the absence of Mg2+ ions. (C) SHAPE reactivities of HCV dom I folded in the absence of magnesium and with (orange
outline) or without (grey outline) 10 mM miR-122. Reactivities shown are the mean of three replicates and are superimposed on the secondary
structures according the legend in Figure 1D.
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remain moderate even in the presence of miR-122,
indicating that no miR-122 is bound at site 1.
Performing the SHAPE experiment on the entire HCV
50UTR reveals Mg2+-induced structural changes through-
out the entire RNA and allows the exploration of possible
tertiary interactions. When we compare the reactivities for
the HCV 50UTR in the absence or presence of Mg2+, the
overall pattern is similar, indicating that the secondary
structure has not been dramatically altered. However,
there are several regions with large reproducible changes
in reactivity, indicating local changes in tertiary structure
(Supplementary Figure S6). Interestingly, there are several
increases in reactivity in dom I on the removal of Mg2+,
likely indicating long-range interactions between this
domain and other parts of the 50UTR, with potential im-
plications for the binding and regulation by miR-122.
There are also increases in reactivity in dom IIb, which
is a reasonable candidate interaction partner for dom I.
Notably, dom II has a bent L-shape architecture (29), and
it is anticipated that these domains are spatially adjacent
based on observations made in the context of the HCV
IRES bound to the 40S or 80S ribosomes (30,31). Other
Mg2+-induced changes in reactivity are seen throughout
dom III, indicating additional possible tertiary inter-
actions with potential implications in 40S and translation
initiation factor eIF3 binding and hence translation of the
viral RNA.
The miR122:HCV interaction imparts stability by
protection from an exonuclease
The mechanism by which miR-122 augments HCV RNA
stability and infectivity remains unknown, but recent
reports have suggested that it may shield the 50 end of
the viral RNA from degradation by cytosolic RNA exo-
nucleases (5,9,10). The 50 end of HCV RNA from HCV
replicon-containing cells is modified with a single phos-
phate, rendering it a potential substrate for the primary
eukaryotic cytosolic 50!30 RNA exonuclease Xrn1
(32,33). We wondered whether the stable complex
detected at the HCV 50 end in the presence of miR-122
(25) functions as a steric block to Xrn1-catalyzed
nucleolytic degradation. To investigate this possibility,
we first tested whether HCV dom I on its own is a sub-
strate for human Xrn1 in vitro. Our results show that 50
monophosphorylated HCV is subject to degradation by
Xrn1 in the absence of miR-122 (Supplementary Figure
S7). Furthermore, prior incubation with miR-122 can
prevent degradation of HCV dom I by Xrn1
(Supplementary Figure S7).
We reasoned that if protection from Xrn1 is the primary
function of miR-122 in stabilizing HCV RNA, then mu-
tations that are detrimental to miR-122 function in vivo
should not protect HCV RNA from Xrn1-mediated deg-
radation. To test this idea, we used three miR-122 mutants
that are defective in supporting HCV RNA levels in a
replicon system (8,9). Two of these mutants, p3p4 and
p8p9 described in this study, contain point mutations
that disrupt HCV 50UTR complex formation, whereas
the third mutant,20–23, lacks the last four 30 nucleotides
of the native miR-122 sequence yet forms a complex with
the HCV 50UTR (Supplementary Figure S8) (9). When
HCV dom I was incubated with these mutated miR-122
RNAs under conditions that support complex formation
with wild-type miR-122, both p3p4 and 20–23 protected
the HCV RNA from subsequent Xrn1-mediated degrad-
ation. In contrast, neither p8p9 nor the unrelated miRNA
miR-124 provided protection from Xrn1-mediated deg-
radation (Figure 6). These results suggest that the ability
of miR-122 to promote HCV infectivity is independent of
its capacity to protect the viral RNA from Xrn1. The
ternary complex formed between the HCV 50UTR and
Figure 6. Susceptibility of 50 monophosphorylated HCV dom I to Xrn1-mediated degradation in the presence of miR-122. Stability of 50
monophosphorylated 30-32P-labelled HCV dom I RNA after incubation with Xrn1 in either the absence or presence of native and mutant
miR-122 RNAs for a period of minutes to 3 h resolved by denaturing gel electrophoresis (top). The percentages of full-length RNA remaining
(below) are shown as the average of two independent experiments with standard deviation shown as error bars with values normalized to the
no-Xrn1 control.
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miR-122 must play additional or alternative roles in vivo,
perhaps through interactions with other cellular factors. It
could be that the affinities of the miR122-RISC
complex to the HCV RNA in cells differ from those
measured by our in vitro system using naked RNA.
These differences in affinities could explain the inconsist-
ent results with Xrn1; however, while this article was
under revision, another study using cell-based assays
reported to observe that miR-122 protects HCV RNA
from 50decay, yet Xrn1 knockdown does not rescue repli-
cation of a viral mutant defective in miR-122 binding (34).
The conclusion of the study was that miR-122 has add-
itional functions in the viral life cycle and is in strong
agreement with the results obtained with our reconstituted
in vitro system.
A unique miRNA:target interaction contributes to an
unconventional function
To explore the possibility that other cytosolic exonucle-
ase(s) act on the HCV RNA 50 end, we tested the stability
of HCV RNA in HepG2 cell lysate in the presence and
absence of native and mutant miR-122 RNAs. Both the
wild-type miR-122 and the p3p4 and 20–23 mutant
miR-122 RNAs were observed to stabilize the HCV
RNA at early time points in HepG2 lysate, compared
with HCV RNA incubated in lysate in the presence of
the unrelated miR-124 or in the absence of miRNA
(Supplementary Figure S9). We also pre-incubated
miR-122 with the HepG2 cell lysate to allow for loading
into Ago2, accounting for the possibility that it is abso-
lutely required for stabilization, which has been done pre-
viously (10). Despite pre-incubation, we saw no enhanced
stabilization of the HCV RNA (Supplementary
Figure S9). These observations support the conclusion
that protection from nucleolytic degradation is not suffi-
cient to explain the role of miR-122:HCV RNA complex
formation in positively regulating HCV RNA levels. A
possible alternative function for miR-122 in forming this
stable tri-molecular complex on the 50 end of HCV is the
recruitment of other protein factors, either directly or
through an Argonaute protein, that can increase infectiv-
ity by promoting viral RNA production, translation or
packaging.
Some published data support the enhanced translation
of HCV RNA on miR-122 binding, although the mechan-
ism is unclear (27,35,36). Our data suggest a possible role
for miR-122 in affecting the global architecture and
dynamics of the HCV IRES, which could in turn affect
the kinetics and thermodynamics of translation initiation.
Future work will be necessary to test this possibility as
well as other functions of the stable tandem miR-
122:HCV 50 end beyond protection of viral RNA from
degradation.
SUPPLEMENTARY DATA
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